Status:

COMPLETED

The Prevalence and Risk Factors of Irritable Bowel Syndrome Among Adults

Lead Sponsor:

University of Aleppo

Conditions:

Irritable Bowel Syndrome

Colonic Diseases, Functional

Eligibility:

All Genders

18+ years

Brief Summary

This is a multicenter cross-sectional study on the prevalence of Irritable Bowel Syndrome and the risk factors associated with it. The Rome IV criteria is used for diagnosing IBS. A questionnaire-guid...

Detailed Description

: Irritable Bowel Syndrome (IBS) is a common functional bowel disorder characterized by abdominal pain or discomfort associated with defecation or an altered bowel habit. IBS can be divided into four ...

Eligibility Criteria

Inclusion

  • Volunteer to participate in the study

Exclusion

  • Poorly-controlled hyperthyroidism
  • Poorly-controlled hypothyroidism
  • Poorly-controlled hyperparathyroidism
  • Liver disease
  • Paralysis
  • Parasitic diseases (worms ...)
  • Celiac disease
  • Inflammatory bowel disease (Crohn's disease or Ulcerative colitis)
  • Lactose intolerance
  • Cancer or tumor in the digestive tract

Key Trial Info

Start Date :

April 25 2022

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 10 2022

Estimated Enrollment :

5500 Patients enrolled

Trial Details

Trial ID

NCT05340400

Start Date

April 25 2022

End Date

June 10 2022

Last Update

June 14 2022

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Ahmad Yamen Arnaout

Aleppo, Syria

2

University of Aleppo

Aleppo, Syria